Trial Profile
A study investigating patterns of 68Ga-DOTA TATE uptake in normal tissues, neuroendocrine tumor metastases, and benign lesions.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Mar 2017
Price :
$35
*
At a glance
- Drugs Gallium 68-DOTATATE (Primary)
- Indications Neuroendocrine tumours
- Focus Pharmacokinetics
- 01 Mar 2017 New trial record